Of these 13 studies: 8 studies (6 articles) assessed the association of DBP gene polymorphisms with MS risk [29–34] and 5 studies (5 articles) investigated the association between DBP gene polymorphisms and risk of T1DM [35–39]. The gene discussed is DBP; the disease is myeloid sarcoma.